Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...

What if the biopharma industry used epidemiology data, rather than the U.S. Census Bureau to build clinical trial rosters? GSK put the idea to the test in a 17-year retroactive study of clinical trial ...

Pharmaceutical company GSK will no longer set diversity targets as it became the latest firm to abandon inclusivity goals.

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president’s opposition to ...